Prognostic factors in advanced stage Hodgkin's lymphoma: the significance of the number of involved anatomic sites

: Background: Advanced Hodgkin's lymphoma (HL) is curable by conventional chemotherapy in 60–70% of patients. The pretreatment identification of a sizeable subgroup of patients with sufficiently low failure‐free survival (FFS) to be eligible for investigational treatment is necessary. Objective...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	European journal of haematology 2001-11, Vol.67 (5-6), p.279-288
Hauptverfasser:	Vassilakopoulos, T.P., Angelopoulou, M.K., Siakantaris, M.P., Kontopidou, F.N., Dimopoulou, M.N., Barbounis, A., Grigorakis, V., Karkantaris, C., Anargyrou, K., Chatziioannou, M., Rombos, J., Boussiotis, V.A., Vaiopoulos, G., Kittas, C., Pangalis, G.A.
Format:	Artikel
Sprache:	eng
Schlagworte:	Adolescent Adult advance stage Aged Antibiotics, Antineoplastic - therapeutic use Biological and medical sciences Disease-Free Survival Female Hematologic and hematopoietic diseases Hodgkin Disease - drug therapy Hodgkin Disease - pathology Hodgkin's lymphoma Humans International Prognostic Score Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis Male Medical sciences Middle Aged Multivariate Analysis Neoplasm Staging number of involved sites Predictive Value of Tests Prognosis prognostic factors Retrospective Studies
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!